Loading clinical trials...
Loading clinical trials...
Behavioral Therapy With and Without GLP-1 Analogue in Patients With Morbid Obesity and Binge Eating Disorder: A Clinical Prospective Observational Study on Body Weight, Binge Eating Behavior, and Harmful Coping Strategies
Conditions
Interventions
GLP-1
CBTe Group Therapy
Locations
1
Norway
Haukeland University Hospital
Bergen, Vestland, Norway
Start Date
July 1, 2025
Primary Completion Date
November 5, 2027
Completion Date
December 31, 2028
Last Updated
September 15, 2025
NCT07212673
NCT06847399
NCT07435974
NCT02940613
NCT05560529
NCT05035927
Lead Sponsor
Haukeland University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions